These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9094080)

  • 1. Quantitative diffusion imaging in implanted human breast tumors.
    Maier CF; Paran Y; Bendel P; Rutt BK; Degani H
    Magn Reson Med; 1997 Apr; 37(4):576-81. PubMed ID: 9094080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging.
    Lyng H; Haraldseth O; Rofstad EK
    Magn Reson Med; 2000 Jun; 43(6):828-36. PubMed ID: 10861877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen enhances cell death in implanted MCF7 breast cancer by inhibiting endothelium growth.
    Haran EF; Maretzek AF; Goldberg I; Horowitz A; Degani H
    Cancer Res; 1994 Nov; 54(21):5511-4. PubMed ID: 7923186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo studies by magnetic resonance imaging and spectroscopy of the response to tamoxifen of MCF7 human breast cancer implanted in nude mice.
    Furman E; Margalit R; Bendel P; Horowitz A; Degani H
    Cancer Commun; 1991 Sep; 3(9):287-97. PubMed ID: 1911045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent development of murine T-cell lymphomas with TcR alpha/beta+, CD4-/8- phenotype after implantation of human inflammatory breast cancer cells in BALB/c nude mice.
    Wakasugi H; Koyama K; Gyotoku M; Yoshimoto M; Hirohashi S; Sugimura T; Terada M
    Jpn J Cancer Res; 1995 Nov; 86(11):1086-96. PubMed ID: 8567401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging and spectroscopy of MCF7 human breast cancer: pathophysiology and monitoring of treatment.
    Degani H; Furman E; Fields S
    Clin Chim Acta; 1994 Jul; 228(1):19-33. PubMed ID: 7955426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of apparent diffusion coefficient values for the differentiation of viable and necrotic areas of breast cancer and its potential utility to guide voxel positioning for MRS in the absence of dynamic contrast-enhanced MRI data.
    Sharma U; Sah RG; Parshad R; Sharma R; Seenu V; Jagannathan NR
    Magn Reson Imaging; 2012 Jun; 30(5):649-55. PubMed ID: 22459442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodality imaging assessments of response to metformin therapy for breast cancer in nude mice.
    Mao Y; Xia R; Wang L; Wang YQ; Gao FB
    Chin Med J (Engl); 2013; 126(19):3717-22. PubMed ID: 24112170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of diffusion-weighted magnetic resonance imaging in differentiation between the viable and necrotic parts of head and neck tumors.
    Razek AA; Megahed AS; Denewer A; Motamed A; Tawfik A; Nada N
    Acta Radiol; 2008 Apr; 49(3):364-70. PubMed ID: 18365828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of tumor characteristics derived from DCE-MRI and DW-MRI with histology in murine models of breast cancer.
    Barnes SL; Sorace AG; Loveless ME; Whisenant JG; Yankeelov TE
    NMR Biomed; 2015 Oct; 28(10):1345-56. PubMed ID: 26332194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
    Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
    Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Predictive value of diffusion-weighted magnetic resonance imaging in patients with esophageal carcinoma treated with radiotherapy: an animal trial].
    Zhang AD; Wang YF; Shi GF; Han C; Zhang J; Wang L; Liu H; Li Y
    Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):102-106. PubMed ID: 30862138
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor initiating cancer stem cells from human breast cancer cell lines.
    Han JS; Crowe DL
    Int J Oncol; 2009 May; 34(5):1449-53. PubMed ID: 19360358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast-enhanced magnetic resonance imaging reveals stress-induced angiogenesis in MCF7 human breast tumors.
    Furman-Haran E; Margalit R; Grobgeld D; Degani H
    Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6247-51. PubMed ID: 8692800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative comparison between the transplantability of human and murine tumors into the subcutaneous tissue of NCr/Sed-nu/nu nude and severe combined immunodeficient mice.
    Taghian A; Budach W; Zietman A; Freeman J; Gioioso D; Ruka W; Suit HD
    Cancer Res; 1993 Oct; 53(20):5012-7. PubMed ID: 8402692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor apparent diffusion coefficient as an imaging biomarker to predict tumor aggressiveness in patients with estrogen-receptor-positive breast cancer.
    Shin HJ; Kim SH; Lee HJ; Gong G; Baek S; Chae EY; Choi WJ; Cha JH; Kim HH
    NMR Biomed; 2016 Aug; 29(8):1070-8. PubMed ID: 27332719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative apparent diffusion coefficient as a noninvasive imaging biomarker for the differentiation of invasive breast cancer and ductal carcinoma in situ.
    Bickel H; Pinker-Domenig K; Bogner W; Spick C; Bagó-Horváth Z; Weber M; Helbich T; Baltzer P
    Invest Radiol; 2015 Feb; 50(2):95-100. PubMed ID: 25333308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basement membrane components (matrigel) promote the tumorigenicity of human breast adenocarcinoma MCF7 cells and provide an in vivo model to assess the responsiveness of cells to estrogen.
    Noel A; Simon N; Raus J; Foidart JM
    Biochem Pharmacol; 1992 Mar; 43(6):1263-7. PubMed ID: 1562280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective early response imaging biomarker for neoadjuvant breast cancer chemotherapy.
    Lee KC; Moffat BA; Schott AF; Layman R; Ellingworth S; Juliar R; Khan AP; Helvie M; Meyer CR; Chenevert TL; Rehemtulla A; Ross BD
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):443-50. PubMed ID: 17255264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing DCE-CT to quantify intra-tumor heterogeneity in breast tumors with differing angiogenic phenotype.
    Cao M; Liang Y; Shen C; Miller KD; Stantz KM
    IEEE Trans Med Imaging; 2009 Jun; 28(6):861-71. PubMed ID: 19150783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.